close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Health & Science Regulations Biogen Inc
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Juniper Networks Inc Business Enphase Energy Inc
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags Progressive Corp Biogen Inc MSCI Inc
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Health care industry Biogen Inc US: News
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Biogen Inc Markets Economy
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Health care industry Breaking news Business News
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Policy Breaking News: Business Health & Science
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Health care industry Business News Business
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags Biogen Inc DraftKings Inc Stock markets
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Breaking News: Markets Meta Platforms Inc Market Insider
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Social issues World Markets Eisai Co Ltd
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags US: News Biotech and Pharmaceuticals Biogen Inc
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags Finance Carnival Corp Zions Bancorporation NA
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Pandemics Social issues Biotechnology
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags US: News Biotech and Pharmaceuticals US Economy
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Investing Food and Beverage Chipotle Mexican Grill Inc
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Biogen Inc US: News Biotech and Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Paycom Software Inc Generac Holdings Inc Cogent Communications Holdings Inc
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags US Top News and Analysis World News Policy
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Quest Diagnostics Inc Quanterix Corp CVS Health Corp
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags US: News Biotech and Pharmaceuticals Biogen Inc
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Eisai Co Ltd Alzheimer's disease Biotechnology
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Biotechnology Breaking news Health care industry
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Biotechnology Eisai Co Ltd Health care industry
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Eisai Co Ltd Biotechnology Pharmaceuticals
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Breaking news Health care industry Biogen Inc
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Breaking News: Business Health & Science Biotechnology
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Biotechnology Pandemics Eisai Co Ltd
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Pandemics Biotechnology Epidemics
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags Eisai Co Ltd Politics Epidemics
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.